|
|
Stem Cell Medicines
Gwo Xi Stem Cell Company is committed to developing innovative technologies and medicines for satisfying unmet medical needs. We adopt modular process design in establishing 'pharmaceutical-grade stem cell preparation and production platform', which includes 'Nigiro-Med® (activating stem cell technology)', 'pharmaceutical-grade stem cell storage service', and 'clinical-grade cell therapy product quality testing service'. Leveraging these technologies and platforms, we have developed several drug candidates to reduce risk during development. Moreover, after persistent efforts, we have successfully put four stem cell medicines into clinical trial.
